secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2022-09-02T23:59:59+00:00
Accession:  0001193125-22-237942
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Edward T. Mathers resigns from Mirum board and compensation committee
------------------------------------------------------------------------------

- Edward T. Mathers resigned as director and from the Compensation Committee effective September 1, 2022.
- Resignation not due to any dispute or disagreement with the company on operations, policies, or practices.
- No replacement for the board vacancy or committee seat was announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312522237942/0001193125-22-237942-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312522237942/d309885d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-237942

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer